Zhongzhi Pharmaceutical Holdings Limited

SEHK:3737 Lagerbericht

Marktkapitalisierung: HK$846.3m

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Zhongzhi Pharmaceutical Holdings Dividende

Zukünftiges Wachstum Kriterienprüfungen 2/6

Zhongzhi Pharmaceutical Holdings ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 5.48%, die durch die Erträge gut gedeckt ist.

Wichtige Informationen

5.9%

Dividendenausschüttung

43%

Ausschüttungsquote

Durchschnittlicher Branchenertrag3.4%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Gewinn pro AktieHK$0.19
Erwartete Dividendenrendite in 3 Jahrenn/a

Aktuelle Dividendenentwicklung

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Recent updates

Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

May 10
Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

May 05
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03

Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

Feb 01
Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

May 24
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Aug 26
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?

Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

Apr 28
Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet

These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well

Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

May 06
Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)

Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Apr 21
Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues

Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

Mar 29
Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?

The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Mar 05
The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 15
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Jan 14
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?

Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

Dec 27
Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?

If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Dec 14
If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late

Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Nov 30
Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?

Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 17
Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: 3737 zahlt seit weniger als 10 Jahren eine Dividende, und während dieser Zeit waren die Zahlungen volatil.

Wachsende Dividende: 3737Die Dividendenzahlungen des Unternehmens sind gestiegen, aber das Unternehmen zahlt erst seit 8 Jahren eine Dividende.


Dividendenrendite im Vergleich zum Markt

Zhongzhi Pharmaceutical Holdings Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von 3737 im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (3737)5.9%
Untere 25 % des Marktes (HK)3.2%
Markt Top 25 % (HK)7.8%
Branchendurchschnitt (Pharmaceuticals)3.4%
Analystenprognose in 3 Jahren (3737)n/a

Bemerkenswerte Dividende: 3737Die Dividende des Unternehmens (5.48%) ist höher als die der untersten 25 % der Dividendenzahler auf dem Markt Hong Kong (3.12%).

Hohe Dividende: 3737Die Dividende des Unternehmens (5.48%) ist im Vergleich zu den besten 25 % der Dividendenzahler auf dem Markt Hong Kong (7.56%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Mit einer relativ niedrigen Ausschüttungsquote (42.5%) sind die Dividendenzahlungen von 3737 gut durch die Erträge gedeckt.


Barausschüttung an die Aktionäre

Cashflow-Deckung: 3737 zahlt eine Dividende, aber das Unternehmen hat keinen freien Cashflow.


Discover strong dividend paying companies